Difluorinated thromboxane A
BRET
F2‐TXA2
F‐TXA2
G‐protein coupled receptor
IP receptor
TP receptor
TXA2
platelets
prostanoids
thromboxane A2
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
05 Jun 2024
05 Jun 2024
Historique:
revised:
21
12
2023
received:
10
10
2023
accepted:
17
01
2024
medline:
6
6
2024
pubmed:
6
6
2024
entrez:
5
6
2024
Statut:
aheadofprint
Résumé
Thromboxane A Platelet functional and signalling responses were studied using aggregometry, Ca BRET studies revealed that F-TXA F-TXA
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Thromboxane A
EXPERIMENTAL APPROACH
METHODS
Platelet functional and signalling responses were studied using aggregometry, Ca
KEY RESULTS
RESULTS
BRET studies revealed that F-TXA
CONCLUSION AND IMPLICATIONS
CONCLUSIONS
F-TXA
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : British Pharmacological Society, A.J. Clark PhD studentship M.K.
Organisme : National Centre for Replacement, Refinement and Reduction of Animals in Research, PhD studentship J.S.T.
Organisme : British Heart Foundation
ID : BHF, PG/20/1/34617
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/4yPhD/F/20/34125
Pays : United Kingdom
Organisme : Engineering and Physical Sciences Research Council
ID : EP/M012530/1
Informations de copyright
© 2024 The Author(s). British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Abbracchio, M. P., Abraham, G., Agoulnik, A., Alexander, W., Al‐Hosaini, K., Bäck, M., Baker, J. G., Barnes, N. M., … Ye, R. D. (2023). The Concise Guide to PHARMACOLOGY 2023/24: G protein‐coupled receptors. British Journal of Pharmacology, 180, S23–S144. https://doi.org/10.1111/bph.16177
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Annett, S., Boison, D., Burns, K. E., Dessauer, C., Gertsch, J., Helsby, N. A., Izzo, A. A., Ostrom, R., Papapetropoulos, A., … Wong, S. S. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Enzymes. British Journal of Pharmacology, 180, S289–S373. https://doi.org/10.1111/bph.16181
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Beuve, A., Brouckaert, P., Bryant, C., Burnett, J. C., Farndale, R. W., Friebe, A., Garthwaite, J., Hobbs, A. J., Jarvis, G. E., … Waldman, S. A. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors. British Journal of Pharmacology, 180, S241–S288. https://doi.org/10.1111/bph.16180
Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Mangum, J., Wonnacott, S., & Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. British Journal of Pharmacology, 175, 407–411. https://doi.org/10.1111/bph.14112
Badimon, L., Vilahur, G., Rocca, B., & Patrono, C. (2021). The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovascular Research, 117(9), 2001–2015. https://doi.org/10.1093/cvr/cvab003
Battram, A. M., Durrant, T. N., Agbani, E. O., Heesom, K. J., Paul, D. S., Piatt, R., Poole, A. W., Cullen, P. J., Bergmeier, W., Moore, S. F., & Hers, I. (2017). The phosphatidylinositol 3,4,5‐trisphosphate (PI(3,4,5)P3) binder Rasa3 regulates phosphoinositide 3‐kinase (PI3K)‐dependent integrin αIIbβ3 outside‐in signaling. The Journal of Biological Chemistry, 292(5), 1691–1704. https://doi.org/10.1074/jbc.M116.746867
Bhagwat, S. S., Hamann, P. R., Still, W. C., Bunting, S., & Fitzpatrick, F. A. (1985). Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature, 315, 511–513. https://doi.org/10.1038/315511a0
Braune, S., Kupper, J.‐H., & Jung, F. (2020). Effect of prostanoids on human platelet function: An overview. International Journal of Molecular Sciences, 21, 9020. https://doi.org/10.3390/ijms21239020
Corso, G., Stärk, H., Jing, B., Barzilay, R., & Jaakkola, T. (2023). DiffDock: diffusion steps, twists, and turns for molecular docking. In International Conference on Learning Representations (ICLR). arXivLabs, arXiv:2210.01776v2.
Curtis, M. J., Alexander, S. P. H., Cirino, G., George, C. H., Kendall, D. A., Insel, P. A., Izzo, A. A., Ji, Y., Panettieri, R. A., Patel, H. H., Sobey, C. G., Stanford, S. C., Stanley, P., Stefanska, B., Stephens, G. J., Teixeira, M. M., Vergnolle, N., & Ahluwalia, A. (2022). Planning experiments: Updated guidance on experimental design and analysis and their reporting III. British Journal of Pharmacology, 179, 1–7. https://doi.org/10.1111/bph.15868
De Simone, I., Baaten, C., Gibbins, J. M., Ten Cate, H., Heemskerk, J. W. M., Jones, C. I., & van der Meijden, P. E. J. (2023). Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation. Journal of Thrombosis and Haemostasis, 21(5), 1289–1306. https://doi.org/10.1016/j.jtha.2023.01.006
di Minno, G., Bertelé, V., Bianchi, L., Barbieri, B., Cerletti, C., Dejana, E., de Gaetano, G., & Silver, M. J. (1981). Effects of an epoxymethano stable analogue of prostaglandin endoperoxides (U‐46619) on human platelets. Thromb Haemtost, 45, 103–106. https://doi.org/10.1055/s-0038-1650143
Fan, H., Chen, S., Yuan, X., Han, S., Zhang, H., Xia, W., Xu, Y., Zhao, Q., & Wu, B. (2019). Structural basis for ligand recognition of the human thromboxane A2 receptor. Nature Chemical Biology, 15(1), 27–33. https://doi.org/10.1038/s41589-018-0170-9
FitzGerald, G. A. (1991). Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists. The American Journal of Cardiology, 68, B11–B15. https://doi.org/10.1016/0002-9149(91)90379-Y
Giesberts, A. N., van Willigen, G., Lapetina, E. G., & Akkerman, J. W. (1995). Regulation of platelet glycoprotein IIb/IIIa (integrin αIIBβ3) function via the thrombin receptor. The Biochemical Journal, 309(Pt 2), 613–620. https://doi.org/10.1042/bj3090613
Hamberg, M., Svensson, J., & Samuelsson, B. (1975). Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. The Biochemist, 72, 29–2998. https://doi.org/10.1073/pnas.72.8.2994
Hirata, T., Ushikubi, F., Kakizuka, A., Okuma, M., & Narumiya, S. (1996). Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. The Journal of Clinical Investigation, 97(4), 949–956. https://doi.org/10.1172/JCI118518
Hunter, R. W., Mackintosh, C., & Hers, I. (2009). Protein kinase C‐mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets. The Journal of Biological Chemistry, 284(18), 12339–12348. https://doi.org/10.1074/jbc.M807536200
Jing, C., Mallah, S., Kriemen, E., Bennett, S. H., Fasano, V., Lennox, A. J. J., Hers, I., & Aggarwal, V. K. (2020). Synthesis, stability, and biological studies of fluorinated analogues of thromboxane A2. ACS Central Science, 6, 995–1000. https://doi.org/10.1021/acscentsci.0c00310
Knezevic, I., Borg, C., & Le Breton, G. C. (1993). Identification of Gq as one of the G‐proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors. The Journal of Biological Chemistry, 268, 26011–26017. https://doi.org/10.1016/S0021-9258(19)74486-X
Li, Z., Zhang, G., Le Breton, G. C., Gao, X., Malik, A. B., & Du, X. (2003). Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3‐kinases. The Journal of Biological Chemistry, 278(33), 30725–30731. https://doi.org/10.1074/jbc.M301838200
Moore, S. F., van den Bosch, M. T., Hunter, R. W., Sakamoto, K., Poole, A. W., & Hers, I. (2013). Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin‐mediated integrin αIIbβ3 activation and granule secretion in platelets. The Journal of Biological Chemistry, 288(6), 3918–3928. https://doi.org/10.1074/jbc.M112.429936
Offermanns, S., Laugwitz, K. L., Spicher, K., & Schultz, G. (1994). G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proceedings of the National Academy of Sciences of the United States of America, 91, 504–508. https://doi.org/10.1073/pnas.91.2.504
Reilly, M., & Fitzgerald, G. A. (1993). Cellular activation by thromboxane A2 and other eicosanoids. European Heart Journal, 14(Suppl K), 88–93.
Schrödinger, L., & DeLano, W. (2020). PyMOL. Available from http://www.pymol.org/pymol
Sledz, K. M., Moore, S. F., Durrant, T. N., Blair, T. A., Hunter, R. W., & Hers, I. (2020). Rapamycin restrains platelet procoagulant responses via FKBP‐mediated protection of mitochondrial integrity. Biochemical Pharmacology, 177, 113975. https://doi.org/10.1016/j.bcp.2020.113975
Stefanini, L., Paul, D. S., Robledo, R. F., Chan, E. R., Getz, T. M., Campbell, R. A., Kechele, D. O., Casari, C., Piatt, R., Caron, K. M., Mackman, N., Weyrich, A. S., Parrott, M. C., Boulaftali, Y., Adams, M. D., Peters, L. L., & Bergmeier, W. (2015). RASA3 is a critical inhibitor of RAP1‐dependent platelet activation. The Journal of Clinical Investigation, 125(4), 1419–1432. https://doi.org/10.1172/JCI77993
Szczeklik, A., Gryglewski, R. J., Musial, J., Grodzinska, L., Serwonska, M., & Marcinkiewicz, E. (1978). Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thrombosis and Haemostasis, 40(1), 66–74. https://doi.org/10.1055/s-0038-1648635
van Willigen, G., & Akkerman, J. W. (1991). Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB‐IIIA complex of human platelets. The Biochemical Journal, 273(Pt 1), 115–120. https://doi.org/10.1042/bj2730115
Walsh, M. T., Foley, J. F., & Kinsella, B. T. (2000). The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin‐mediated desensitization. The Journal of Biological Chemistry, 275(27), 20412–20423. https://doi.org/10.1074/jbc.M907881199
Zatta, A., & Prosdocimi, M. (1989). Platelet activation induced by a stable analogue of endoperoxides (U46619). Thrombosis and Haemostasis, 61, 328–329. https://doi.org/10.1055/s-0038-1646590
Zou, J., Swieringa, F., de Laat, B., de Groot, P. G., Roest, M., & Heemskerk, J. W. M. (2022). Reversible platelet integrin αIIbβ3 activation and thrombus instability. International Journal of Molecular Sciences, 23(20), 12512. https://doi.org/10.3390/ijms232012512
Zou, J., Wu, J., Roest, M., & Heemskerk, J. W. M. (2021). Long‐term platelet priming after glycoprotein VI stimulation in comparison to protease‐activating receptor (PAR) stimulation. PLoS ONE, 16(3), e0247425. https://doi.org/10.1371/journal.pone.0247425